Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Arthralgia|Osteoporosis
Interventions: DRUG: Testosterone
Sponsor: Havah Therapeutics Pty Ltd
Collaborators: AstraZeneca